| Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis D Adams, A Gonzalez-Duarte, WD O’Riordan, CC Yang, M Ueda, ... New england journal of medicine 379 (1), 11-21, 2018 | 2589 | 2018 |
| Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy MS Maurer, JH Schwartz, B Gundapaneni, PM Elliott, G Merlini, ... New England Journal of Medicine 379 (11), 1007-1016, 2018 | 2204 | 2018 |
| Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases P Garcia-Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European heart journal 42 (16), 1554-1568, 2021 | 776 | 2021 |
| ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of … S Dorbala, Y Ando, S Bokhari, A Dispenzieri, RH Falk, VA Ferrari, ... Circulation: Cardiovascular Imaging 14 (7), e000029, 2021 | 705* | 2021 |
| Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis MS Maurer, S Bokhari, T Damy, S Dorbala, BM Drachman, M Fontana, ... Circulation: Heart Failure 12 (9), e006075, 2019 | 479 | 2019 |
| Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) MS Maurer, M Hanna, M Grogan, A Dispenzieri, R Witteles, B Drachman, ... Journal of the American College of Cardiology 68 (2), 161-172, 2016 | 460 | 2016 |
| Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis: analysis of the APOLLO study SD Solomon, D Adams, A Kristen, M Grogan, A González-Duarte, ... Circulation 139 (4), 431-443, 2019 | 446 | 2019 |
| Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers SJ Buss, M Emami, D Mereles, G Korosoglou, AV Kristen, A Voss, ... Journal of the American College of Cardiology 60 (12), 1067-1076, 2012 | 321 | 2012 |
| Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis AV Kristen, S Ajroud-Driss, I Conceição, P Gorevic, T Kyriakides, L Obici Neurodegenerative disease management 9 (1), 5-23, 2019 | 282 | 2019 |
| Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death AV Kristen, TJ Dengler, U Hegenbart, SO Schonland, H Goldschmidt, ... Heart rhythm 5 (2), 235-240, 2008 | 281 | 2008 |
| Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases P Garcia‐Pavia, C Rapezzi, Y Adler, M Arad, C Basso, A Brucato, ... European journal of heart failure 23 (4), 512-526, 2021 | 273 | 2021 |
| Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension FJ Meyer, D Lossnitzer, AV Kristen, AM Schoene, W Kübler, HA Katus, ... European Respiratory Journal 25 (1), 125-130, 2005 | 228 | 2005 |
| Green tea halts progression of cardiac transthyretin amyloidosis: an observational report AV Kristen, S Lehrke, S Buss, D Mereles, H Steen, P Ehlermann, S Hardt, ... Clinical Research in Cardiology 101, 805-813, 2012 | 168 | 2012 |
| Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) T Damy, AV Kristen, OB Suhr, MS Maurer, V Plante-Bordeneuve, CR Yu, ... European heart journal 43 (5), 391-400, 2022 | 162 | 2022 |
| Non‐invasive predictors of survival in cardiac amyloidosis AV Kristen, JB Perz, SO Schonland, U Hegenbart, PA Schnabel, ... European journal of heart failure 9 (6-7), 617-624, 2007 | 146 | 2007 |
| Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study D Adams, M Polydefkis, A González-Duarte, J Wixner, AV Kristen, ... The Lancet Neurology 20 (1), 49-59, 2021 | 134 | 2021 |
| In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography J Kollmer, E Hund, B Hornung, U Hegenbart, SO Schönland, C Kimmich, ... Brain 138 (3), 549-562, 2015 | 125 | 2015 |
| Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay AV Kristen, E Giannitsis, S Lehrke, U Hegenbart, M Konstandin, ... Blood, The Journal of the American Society of Hematology 116 (14), 2455-2461, 2010 | 124 | 2010 |
| Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy? F aus dem Siepen, S Hein, S Prestel, C Baumgärtner, S Schönland, ... Clinical Research in Cardiology 108, 1324-1330, 2019 | 113 | 2019 |
| Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe … S Dietrich, SO Schönland, A Benner, T Bochtler, AV Kristen, J Beimler, ... Blood, The Journal of the American Society of Hematology 116 (4), 522-528, 2010 | 112 | 2010 |
